Title
Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: A qualitative study
Date Issued
01 February 2017
Access level
metadata only access
Resource Type
journal article
Publisher(s)
International Union against Tubercul. and Lung Dis.
Abstract
S E T T ING: In 2012, Peru's National TB Program (NTP) reported approximately 2400 incident cases of tuberculosis (TB) disease in children aged ,15 years. Peru's TB burden is concentrated in the Lima metropolitan area, particularly in poor districts such as El Agustino and La Victoria, where this study was conducted. OBJECTIVE : To identify barriers to the treatment of childhood tuberculous infection and TB disease in Lima from the perspective of front-line providers and patients' families. D E S I G N : We conducted 10 semi-structured focus groups with 53 purposefully sampled primary care providers, community health workers, and parents/ guardians of pediatric TB patients. We also completed nine in-depth interviews with National TB Program administrators and pulmonologists specializing in TB. Two authors performed inductive thematic analysis and identified emerging themes. RESULT S : Four main treatment barriers emerged from the data: 1) dosing errors, 2) time-and labor-intensive preparation and administration of medications, 3) provider concern that isoniazid preventive therapy (IPT) generates isoniazid resistance, and 4) poor adherence to IPT. CONCLUS ION: Our findings highlight the urgent need for child-friendly formulations, provider and parent/ guardian education about IPT, and strategies to promote adherence to IPT, including support and supervision by health workers and/or regimens with fewer doses.
Start page
154
End page
160
Volume
21
Issue
2
Language
English
OCDE Knowledge area
Sistema respiratorio
Scopus EID
2-s2.0-85015230117
PubMed ID
Source
International Journal of Tuberculosis and Lung Disease
ISSN of the container
10273719
Sponsor(s)
The David Rockefeller Center for Latin American Studies at Harvard University, Boston, MA, USA, funded this study. SSC was supported by National Institutes of Health, Bethesda, MD, USA (T32DA013911).
Sources of information: Directorio de Producción Científica Scopus